Central nervous system congenital malformations in a developing country: Issues and challenges against their prevention

Child's Nervous System

Volumn 26, Issue 7, 2010, Pages 919-924

  Adeleye, Amos Olufemi ^a,b   Dairo, Magbagbeola D ^a   Olowookere, Kayode G ^b  

^a UNIVERSITY OF IBADAN   (Nigeria)

^b LAGOS STATE UNIVERSITY TEACHING HOSPITAL   (Nigeria)

Author keywords

Congenital CNS anomaly; Developing countries; Folic acid supplementation; Nigeria; Obstetric neurosonography; Prevention

Indexed keywords

FOLIC ACID; TRACE ELEMENT;

ARTICLE; CENTRAL NERVOUS SYSTEM MALFORMATION; CHILD; CLINICAL TRIAL; CRANIOFACIAL SYNOSTOSIS; CROSS-SECTIONAL STUDY; DEVELOPING COUNTRY; DIET SUPPLEMENTATION; EDUCATIONAL STATUS; ENCEPHALOCELE; ENCEPHALOMYELOCELE; FEMALE; FETUS ECHOGRAPHY; GESTATIONAL AGE; HUMAN; HYDROCEPHALUS; INFANT; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; MENINGOMYELOCELE; NEURAL TUBE DEFECT; NEUROSURGERY; NEWBORN; NIGERIA; PRENATAL DIAGNOSIS; PRESCHOOL CHILD; PRIMARY PREVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SECONDARY PREVENTION; SPINE MALFORMATION; VITAMIN SUPPLEMENTATION;

ADULT; CROSS-SECTIONAL STUDIES; DEVELOPING COUNTRIES; FEMALE; GESTATIONAL AGE; HEALTH BEHAVIOR; HUMANS; INFANT; INFANT, NEWBORN; NERVOUS SYSTEM MALFORMATIONS; NIGERIA; OBSTETRICS; PREGNANCY; PRENATAL CARE; PROSPECTIVE STUDIES; SOCIOECONOMIC FACTORS; ULTRASONOGRAPHY, PRENATAL;

EID: 77956186742     PISSN: 02567040     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00381-009-1079-0     Document Type: Article

References (24)

1. Oakeshott P, Hunt GM (2003) Long-term outcome in open spina bifida. Br J Gen Pract 53:632-636
2. Tuli S, Tuli J, Drake J, Spears J (2004) Predictors of death in pediatric patients requiring cerebrospinal fluid shunts. J Neurosurg Pediatr 100:442-446
3. Ouyang L, Grosse SD, Armour BS, Waitzman NJ (2007) Health care expenditures of children and adults with Spina Bifida in a privately insured U. S. population. Birth Defects Res (Part A) 79:552-558
4. Harris MB, Banta JB (1990) Cost of skin care in the myelomeningocele population. J Pediatr Orthop 10:355-361
5. Oakley GP, Brent RL (2008) Birth defects prevention: -The Fierce Urgency of Now-. Birth Defects Res (Part A) 82:745-747
6. Padmanabhan R (2006) Etiology, pathogenesis and prevention of neural tube. Cong Anom (Kyoto) 46:55-67
7. Aslan H, Yildirim G, Ongut C, Ceylan Y (2007) Termination of pregnancy for fetal anomaly. Int J Gynaecol Obstet 99:221-224
8. Vaknin Z, Ben-Ami I, Reish O, Herman A, Maymon R (2006) Fetal abnormalities leading to termination of singleton pregnancy: the 7-year experience of a single medical center. Prenat Diagn 26:938-943
9. Njamnshi AK, de Paul Djientcheu V, Lekoubou A, Guemse M, Obama MT, Mbu R, Takongmo S, Kago I (2008) Neural tube defects are rare among black Americans but not in sub-Saharan black Africans: the case of Yaounde-Cameroon. J Neurol Sci 270:13-17
10. de Paul Djientcheu V, Njamnshi AK, Wonkam A, Njiki J, Guemse M, Mbu R, Obama MT, Takongmo S, Kago I, Tetanye E, Tietche F (2008) Management of neural tube defects in a sub-Saharan African country: The situation in Yaounde, Cameroon. J Neurol Sci 275:29-32
11. Sayed AR, Bourne D, Pattinson R, Nixon J, Henderson B (2008) Decline in the prevalence of neural tube defects following folic acid fortification and its cost-benefit in South Africa. Birth Defects Res A Clin Mol Teratol 82:211-216
12. Oakley GP, Bell KN (2009) Update on prevention of folic acidpreventable Spina Bifida and anencephaly. Birth Defects Res (Part A) 85:102-107
13. Ekanem TB, Okon DE, Akpantah AO, Mesembe OE, Eluwa MA, Ekong MB (2008) Prevalence of congenital malformations in Cross River and Akwa Ibom states of Nigeria from 1980-2003. Cong Anom (Kyoto) 48:167-170
14. Hadzagic-Catibusic F, Maksic H, Uzicanin S, Hadzagic-Catibusic S, Zubcevic S, Merhemic Z, Cengic A, Kulenovic E (2008) Congenital malformations of the central nervous system: clinical approach. Bosn J Basic Med Sci 8:356-360
15. Rasmussen SA, Erickson JD, Reef SE, Ross DS (2009) Teratology: from science to birth defects prevention. Birth Defects Res (Part A) 85:82-92
16. Botto LD, Moore CA, Khoury MJ, Erickson JD (1999) Neuraltube defects. N Engl J Med 341:1509-1519
17. Berry RJ, Li Z, Erickson JD, Li S, Moore CA, Wang H, Mulinare J, Zhao P, Wong LC, Gindler J, Hong S, Correa A (1999) Prevention of neural-tube defects with folic acid in China. China- US collaborative project for neural tube defect prevention. N Engl J Med 341:1485-1490
18. De Wals P, Tairou F, Van Allen MI, Uh SH, Lowry RB, Sibbald B, Evans JA, Van den Hof MC, Zimmer P, Crowley M, Fernandez B, Lee NS, Niyonsenga T (2007) Reduction in neural-tube defects after folic acid fortification in Canada. N Engl J Med 357:135-142
19. Llanos A, Hertrampf E, Cortes F, Pardo A, Grosse SD, Uauy R (2007) Cost-effectiveness of a folic acid fortification program in Chile. Health Policy 83:295-303
20. Mehta TS, Deborah L (2005) Imaging of fetal cerebral ventriculomegaly: a guide to management outcome. Semin Fetal Neonatal Med 10:421-428
21. Verrotti C, Caforio E, Gramellini D, Nardelli GB (2007) Ultrasound screening in second and third trimester of pregnancy: an update. Acta Biomed 78:229-232
22. Antonsson P, Sundberg A, Kublickas M, Pilo C, Ghazi S, Westgren M, Nikos P (2008) Correlation between ultrasound and autopsy findings after 2nd trimester termination of pregnancy. J Perinat Med 36:59-69
23. Grandjean H, Larroque D, Salvator L, Eurofetus Study Group (1999) The performance of routine ultrasonographic screening of pregnancies in the Eurofetus Study. Am J Obstet Gynecol 181:446-454
24. WHO (2009) WHO Statistical Information system: world health statistics 2009. Accessed at http://www.who.int/whosis/whostat/2009/en/index.html